High Incidence of Paralytic Ileus After Bortezomib Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients: Report of 2 Cases.
1 Department of Nephrology, Hospital Clinic Barcelona, Barcelona, Spain. 2 Laboratori Experimental de Nefrologia i Trasplantament (LENIT), CRB CELLEX, IDIBAPS, Barcelona, Spain. 3 Department of Hemotherapy and Hemostasis, Hospital Clinic Barcelona, Barcelona, Spain.
Erika
E
De Sousa-Amorim
Ignacio
I
Revuelta
Fritz
F
Diekmann
Frederic
F
Cofan
Joan
J
Cid
Miquel
M
Lozano
Josep María
JM
Campistol
Federic
F
Oppenheimer
D000069286:Bortezomib / Q000009:adverse effects*; D005260:Female; D006084:Graft Rejection / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D056724:Immunity, Humoral; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D015994:Incidence; D007418:Intestinal Pseudo-Obstruction / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D061988:Proteasome Inhibitors / Q000009:adverse effects*; D020127:Recovery of Function; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D061988:Proteasome Inhibitors; D000069286:Bortezomib